LHRH, Phe(2)-Pro(3)-Phe(6)-

Modify Date: 2025-08-27 11:46:26

LHRH, Phe(2)-Pro(3)-Phe(6)- Structure
LHRH, Phe(2)-Pro(3)-Phe(6)- structure
Common Name LHRH, Phe(2)-Pro(3)-Phe(6)-
CAS Number 64789-67-9 Molecular Weight 1193.35000
Density 1.44g/cm3 Boiling Point N/A
Molecular Formula C59H80N14O13 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of LHRH, Phe(2)-Pro(3)-Phe(6)-


[D-Phe2,6, Pro3]-LH-RH is a potent luteinizing hormone releasing hormone (LHRH) antagonist[1].

 Names

Name 5-Oxo-L-prolyl-D-phenylalanyl-L-prolyl-L-seryl-L-tyrosyl-D-phenylalanyl-L-leucyl-N5-(diaminomethylene)-L-ornithyl-L-prolylglycinamide

 LHRH, Phe(2)-Pro(3)-Phe(6)- Biological Activity

Description [D-Phe2,6, Pro3]-LH-RH is a potent luteinizing hormone releasing hormone (LHRH) antagonist[1].
Related Catalog
In Vitro [D-Phe2,6, Pro3]-LH-RH (0.1 pM-1 mM; 24 h) does not alter GnRH binding capacity in pituitary cells but blocks the increase in sites induced by GnRH[2]. [D-Phe2,6, Pro3]-LH-RH (2.7 μM) causes significant increases in thyrotropin (TSH) secretion in pituitaries[3].
In Vivo [D-Phe2,6, Pro3]-LH-RH (300 mg/monkey, SC, 50 mg/injection; six injections) inhibits spontaneous preovulatory gonadotropin surges and prevents ovulation in the rhesus monkey[1]. [D-Phe2,6, Pro3]-LH-RH (750 μg, single injection at 12:00 h on the day of proestrus) inhibits ovulation in 100% of treated rats[1]. Animal Model: Adult rhesus monkeys[1] Dosage: 300 mg/monkey Administration: SC, every 8 h at a dose of 50 mg/injection; six injections Result: Showed antagonistic activity: 1) an immediate cessation of the LU and FSH surges; 2) prolonged surges and/or abnormal, discontinuous gonadotropin secretion; 3) LH and FSH peaks of diminished magnitude; 4) the absence of concomitant LH and FSH midcycle peaks; 3) LH and FSH peaks of diminished magnitude; 4) the absence of concomitant LH and FSH midcycle peaks; 5) suppression of serum estradiol concentrations without concurrent reductions in serum gonadotropin values; or 6) a failure to identify corpora lutea at the time of laparoscopic visualization of the ovaries.
References

[1]. Wilks JW, et al. Effect of [D-Phe2, Pro3, D-Phe6]-luteinizing hormone releasing hormone, an antagonist, on preovulatory gonadotropin secretion in the rhesus monkey. Biol Reprod. 1980 Aug;23(1):1-9.

[2]. Loumaye E, et al. Homologous regulation of gonadotropin-releasing hormone receptors in cultured pituitary cells. Science. 1982 Feb 19;215(4535):983-5.

[3]. Gian, et al. TRH, LHRH and Synthetic [D-Phe2-6, Pro3]-LHRH Stimulate in Vitro Thyrotropin Secretion by Crested Newt Pituitaries. TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY. 1998;839(1):522-523.

 Chemical & Physical Properties

Density 1.44g/cm3
Molecular Formula C59H80N14O13
Molecular Weight 1193.35000
Exact Mass 1192.60000
PSA 421.37000
LogP 2.32480
Index of Refraction 1.679
InChIKey WYGRGFSYVORMAZ-NIOTWYNPSA-N
SMILES CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(N)=O
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

LHRH, Phe(2)-Pro(3)-Phe(6)- suppliers

LHRH, Phe(2)-Pro(3)-Phe(6)- price

Related Compounds: More...
LHRH, Phe(2)-Trp(3)-Phe(6)-
63722-14-5
LHRH,(N)-Ac-Trp(1)-(4-Cl-Phe)(2)-Trp(3)-Phe(6)-AlaNH2(10)-
78493-59-1
dibenzylideneglicine anhydride
1233-98-3
LHRH, Ac-dehydro-Pro(1)-4-Cl-Phe(2)-Trp(3,6)-
80152-22-3
LHRH, N-Ac-Pro(1)-(4-Cl-Phe)(2)-(2-naphthyl-Ala)(3,6)-
82778-57-2
LHRH, Phe(2)-Trp(6)-
67190-22-1
LHRH, Phe(2)-N-epsilon-(2,4)-dinitrophenol-Lys(6)-
100304-55-0
LHRH, Pro(1)-Phe(2)-Trp(3,6)-
69770-59-8
LHRH, N-Ac-3(2-naphthyl)Ala(1)-Phe(2,3)-Arg(6)-Phe(7)-AlaNH2(10)-
110014-25-0
N-(4-methylbenzyl)-2-((5-oxo-4-phenethyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl)thio)acetamide
1111020-69-9
2-((7-chloro-5-oxo-4-propyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl)thio)-N-(2-chlorobenzyl)acetamide
1110980-67-0
N-(4-ethylphenyl)-2-((4-(3-isopropoxypropyl)-5-oxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl)thio)acetamide
1111020-14-4
N-(4-methoxyphenyl)-2-((5-oxo-4-phenethyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl)thio)acetamide
1111151-41-7
N-(4-fluorophenyl)-2-((5-oxo-4-phenethyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl)thio)acetamide
1111039-01-0
N-benzyl-2-(4-(4-fluorobenzyl)-1,5-dioxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-2(1H)-yl)acetamide
1242983-64-7
N-cyclohexyl-2-(4-(4-fluorobenzyl)-1,5-dioxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-2(1H)-yl)acetamide
1296346-63-8
N-(3,5-dimethylphenyl)-2-(1,5-dioxo-4-phenethyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-2(1H)-yl)acetamide
1242962-92-0
N-(3,4-dimethylphenyl)-2-((4-(3-isopropoxypropyl)-5-oxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl)thio)acetamide
1110979-85-5
N-[4-({4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]-3,4-dimethylbenzamide
1110978-36-3